|
|
|
|
|
|
|
|
|
|
Bafna Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
532989
|
|
ISIN Demat |
INE878I01022
|
|
Book Value (Rs) |
33.57
|
|
|
NSE Code |
BAFNAPH
|
|
Dividend Yield % |
0.00
|
|
Market Cap(Rs Mn) |
2359.72
|
|
|
TTM PE(x) |
20.95
|
|
TTM EPS(Rs) |
4.76
|
|
Face Value (Rs) |
10
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
Incorporation Year
|
1995
|
|
Registered Office
|
Bafna Towers,New No 68, Old No.299,Thambu Chetty Street, Chennai,
Tamil Nadu-600001 .
|
|
ISINNO
|
INE878I01022
|
|
Phone
|
044- 25267517 / 25270992 / 42677555
|
|
E-mail
|
info@bafnapharma.com |
|
URL
|
www.bafnapharma.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Shanmugam Hemalatha
|
|
Managing Director
|
|
|
Company Secretary
|
|
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|